Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder

Clinical trial NCT04987658 · COMPLETED

Trial details

NCT number: NCT04987658
Sponsor: Alkermes, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bipolar I Disorder

Start date: 2021-07-22
Primary completion: 2023-08-11
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.